A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing
Authors:
- A PollAPA Poll
- R RoyerRRR Royer
- S NandaSNS Nanda
- M LlacuachaquiMLM Llacuachaqui
- P SunPSP Sun
- S A NarodS A Narod
Open Access
- 18 June 2013
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 109 (3) , 777-779
Abstract
Guidelines for genetic testing for BRCA1 or BRCA2 stipulate that a personal or family history of cancer is necessary to be eligible for testing. Approximately 2% of Ashkenazi Jewish women carry a mutation, but to date population-based testing has not been advocated. Little is known about the relative yield of a conventional genetic testing programme versus a programme of widespread testing in a population with common founder mutations. We provided both referral-based and Jewish population-based testing between 2008 and 2012. We compared the numbers of BRCA mutation carriers identified through the two streams and estimated the number of genetic counselling hours devoted to each programme. From 2008 to 2012, 38 female carriers were identified through 487 referrals to our genetics centre (29 unaffected with cancer). During the same time, 6179 Jewish women were tested through our population-based programme and 93 mutation carriers were identified (92 unaffected with cancer). Fewer counsellor hours were devoted to the population-based than to the clinical referral-based testing programme. Genetic testing of all Jewish women above the age of 25 years will greatly expand the number of BRCA mutation carriers identified without a commensurate increase in the number of hours required for counselling.Keywords
This publication has 9 references indexed in Scilit:
- What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?The Breast, 2012
- Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screeningBreast Cancer Research and Treatment, 2012
- Patient satisfaction and cancer‐related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2Clinical Genetics, 2010
- Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish WomenJournal of Clinical Oncology, 2010
- Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based studyGynecologic Oncology, 2009
- A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer familiesHuman Mutation, 2002
- Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesJournal of Medical Genetics, 2002
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996